to Precision Medicine
Sanicka is providing healthcare organizations with critical data to support patient-specific leukemia treatment.
We believe every cancer patient deserves precision medicine. Sanicka’s πChemo-Immuno Therapy (πCITTM) platform provides healthcare professionals with predictive precision medicine tools to improve patient outcomes. We are working to improve the patient experience through interactive visualization tools of dynamic treatment responses and outcomes.
πCIT™ is a clinical decision support tool for the selection and optimization of treatment for patients with acute myeloid leukemia
The core of the technology is a mechanistic/deterministic algorithm that uses patient- and tumor-specific data to simulate the response to different treatment alternatives, providing dynamic predictions of the tumor response and patient recovery prior, during and after therapy.
Professor, BME (GTech/Emory)
Bioprocess Engineer
Assoc Professor, HemOnc (Emory) Leukemia
